Colgate Palmolive (CL) Net Income towards Common Stockholders (2009 - 2026)
Colgate Palmolive (CL) posted Net Income towards Common Stockholders of $719.0 million for Q2 2026, up 5.58% on a QoQ basis from $681.0 million in Q1 2026, and down 6.99% year-over-year from $773.0 million in Q2 2025.
Analysis
Colgate Palmolive (CL) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
Colgate Palmolive has reported Net Income towards Common Stockholders for 18 years, with the latest figure at $719.0 million in Q2 2026.
- On a quarterly basis, Net Income towards Common Stockholders fell 6.99% year-over-year to $719.0 million in Q2 2026; TTM through Jun 2026 was $2.2 billion, a 29.24% decrease from a year earlier, with the FY2025 full-year figure at $2.3 billion, down 25.84% from the prior year.
- Net Income towards Common Stockholders was $719.0 million for Q2 2026 at Colgate Palmolive, up from $681.0 million in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was $779.0 million in Q4 2024, with the low at -$5.0 million in Q4 2025.
- Average Net Income towards Common Stockholders over 5 years is $618.5 million, with a median of $722.5 million recorded in 2025.
- The sharpest annual moves came in 2023 and 2025: Net Income towards Common Stockholders jumped 1667.44% in 2023, then tumbled 100.64% in 2025.
- Over 5 years, Net Income towards Common Stockholders stood at $43.0 million in 2022, then surged by 1667.44% to $760.0 million in 2023, then gained by 2.5% to $779.0 million in 2024, then sank by 100.64% to -$5.0 million in 2025, then soared by 14480.0% to $719.0 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at $719.0 million (Q2 2026), $681.0 million (Q1 2026), and -$5.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.16 Bn | 68.79 Bn | 3.30 Bn | 719.00 Mn |
| 2 | Kenvue | 34.57 Bn | 33.46 Bn | 2.30 Bn | 456.00 Mn |
| 3 | Kimberly Clark | 33.33 Bn | 32.38 Bn | 1.60 Bn | 295.00 Mn |
| 4 | Bath & Body Works | 3.95 Bn | 3.16 Bn | 692.00 Mn | 118.00 Mn |
| 5 | Prestige Consumer Healthcare | 2.36 Bn | 2.30 Bn | - | - |
| 6 | Perrigo | 1.99 Bn | 1.59 Bn | 313.90 Mn | 74.40 Mn |
| 7 | Herbalife | 1.27 Bn | 897.09 Mn | 1.03 Bn | -26.50 Mn |
| 8 | Edgewell Personal Care | 1.26 Bn | 861.89 Mn | 242.50 Mn | 13.70 Mn |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Honest Company | 621.22 Mn | 515.32 Mn | 40.36 Mn | 10.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 719.00 Mn |
| Mar 31, 2026 | 681.00 Mn |
| Dec 31, 2025 | -5.00 Mn |
| Sep 30, 2025 | 766.00 Mn |
| Jun 30, 2025 | 773.00 Mn |
| Mar 31, 2025 | 726.00 Mn |
| Dec 31, 2024 | 779.00 Mn |
| Sep 30, 2024 | 776.00 Mn |
| Jun 30, 2024 | 767.00 Mn |
| Mar 31, 2024 | 729.00 Mn |
| Dec 31, 2023 | 760.00 Mn |
| Sep 30, 2023 | 747.00 Mn |
| Jun 30, 2023 | 534.00 Mn |
| Mar 31, 2023 | 414.00 Mn |
| Dec 31, 2022 | 43.00 Mn |
| Sep 30, 2022 | 682.00 Mn |
| Jun 30, 2022 | 639.00 Mn |
| Mar 31, 2022 | 603.00 Mn |
| Dec 31, 2021 | 188.00 Mn |
| Sep 30, 2021 | 681.00 Mn |